GlassScriptPhysician profile
Natasha Mistry
NPI 1902507726
$754.95
in general payments reported to CMS, 2019-2025
15 companies · $550 in 2025
The $550 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $205 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $168.41 | 2025 | Dupixent |
| Galderma Laboratories, L.P. | $150.00 | 2025 | Nemluvio |
| Verrica Pharmaceuticals INC. | $98.18 | 2024 | Ycanth |
| Ars Pharmaceuticals Operations, INC. | $45.26 | 2025 | Neffy |
| Genzyme Corporation | $39.89 | 2025 | |
| Glaxosmithkline, LLC. | $39.65 | 2024-2025 | Nucala |
| Ucb, INC. | $35.07 | 2025 | Bimzelx |
| Medtronic, INC. | $33.68 | 2024 | Propel |
| Leo Pharma INC. | $28.81 | 2025 | Spevigo |
| Ani Pharmaceuticals, INC. | $24.11 | 2025 | Veregen |
| Optinose US, INC. | $22.98 | 2024 | |
| Incyte Corporation | $20.88 | 2025 | Opzelura |
| Vertical Pharmaceuticals, LLC | $17.77 | 2024 | Dsuvia |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.17 | 2025 | Cabtreo |
| Phadia US INC. | $14.09 | 2024 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Mistry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.